Which antidotes are available for the novel oral anticoagulants?

    loading  Checking for direct PDF access through Ovid

Abstract

Use of novel (or target-specific) oral anticoagulants continues to increase. This article reviews idarucizumab and andexanet alfa, two antidotes that can be used to reverse anticoagulation in patients needing emergency surgery or with life-threatening bleeding.

Related Topics

    loading  Loading Related Articles